Page 97 - 2020 NZ Hereford Magazine
P. 97

Industry Focus

          A history of



          Boehringer




          Ingelheim







          WORDS KATE TAYLOR PHOTOGRAPHS SUPPLIED


          BOEHRINGER INGELHEIM WAS FOUNDED IN 1885 by Albert
          Boehringer in Ingelheim am Rhein, Germany.
            After 135 years, Boehringer Ingelheim is one of the world’s
          largest pharmaceutical companies – and the largest private one
          – and is still wholly owned by the Boehringer family. The city of
          Ingelheim is about twice the size of Gore (or the size of Levin)
          and about a third of the town work for the company.   for the past 60 years, with the old heritage products making
            Boehringer Ingelheim is a global group of companies   up a large part of our business but with the addition of part of
          employing more than 50,000 people. As part of research and   the Boehringer Ingelheim range, such as the swine vaccines,
          development activities for innovative drugs, the company focuses   NSAIDs, and other novel livestock treatments.”
          primarily  on  the  therapeutic  areas  of  cardiovascular  disease,   David joined the company (when it was MSD AgVet) in 1993
          respiratory diseases, diseases of the central nervous system,   in Manawatu and Feilding, where he had previously worked for
          metabolic diseases, virological diseases, and oncology.   Wrightson. The regional manager at the time was John Gillies, who
            Having started in the realm of human health, it expanded into   had worked at the Masterton research farm where Ivermectin was
          animal health in the US in the 1970s. Achieving many milestones   trialled. Gillies was instrumental in setting up the original sponsorship
          across the business, it became a market leader in animal health in   with New Zealand Herefords (NZH) that is still going today. David
          New Zealand in 2016. Regional business manager David Dodge   took over from him in 1997 and remembers being introduced to
          takes up the story two decades earlier.               the NZH board at Hereford House on Kimbolton Road, including
            “We started off originally as MSD AgVet. We launched in the   Richard Barnett, father of current board member Philip Barnett.
          early 60s with the first BZ drench called Thiabendazole; that was   “I have been looking after our association with New Zealand
          the first of the white drenches in New Zealand and was a real   Herefords ever since,” David says.
          breakthrough for New Zealand sheep farmers. It revolutionised   “We’ve recently been involved with the youth side as well, but
          control of internal  parasites in sheep and  was  the start of the   we have been the association’s animal health sponsor for the past
          association with New Zealand farmers. Then in the early 80s, we   30 years at national bull sale level, Royal Show level in Hawke’s Bay
          launched another action family, Ivermectin, that was another big   and Canterbury, and getting involved in local sponsorships at local
          breakthrough, this time for sheep and cattle.”        breeder sales such as Maungahina, Mokairau and Wilencote on
            In 1997, MSD Agvet changed to Merial under a joint venture
          arrangement between America’s MSD and French company   TOP: David Dodge started working for the company that eventually
                                                                morphed into Boehringer Ingelheim in the 1960s.
          Sanofi. In 2012, Merial bought Ancare, and then in 2016, it was   BELOW, LEFT TO RIGHT: Boehringer Ingelheim’s David Dodge
          bought by Boehringer Ingelheim.                       discusses the weather with stud breeder Geof Brown on a Hereford
            “Boehringer Ingelheim was big in swine and poultry vaccines   herd tour in Southland in 2010; At the 2019 Royal Show hosted by
          globally and didn’t have a big footprint in the livestock production   the Hawke’s Bay A&P Society, left to right: Paul Fitzpatrick, senior
                                                                product manager Boehringer Ingelheim, World Hereford Conference
          business. By 2017 it was one of the global leaders,” David says.   Young Breeders competition organiser Rebecca Paterson, NZHA
          “Our business in New Zealand remains the same as it has been   manager Posy Moody, and David Dodge, Boehringer Ingelheim.


















                                                                                                                 95
   92   93   94   95   96   97   98   99   100   101   102